Orphazyme: H1 report shows progress
Research Note
2018-08-28
14:17
The first half of 2018 has been filled with operational progress. All four clinical trials are now up-and-running and key clinical data is expected for the NPC Phase II/III trial in Q3 2018.
MS
Mathias Spinnars
Disclosures and disclaimers